CTRI/2022/07/044382尚未招募未知
Randomized controlled parallel group add on clinical study to assess the efficacy of Kanchanar Triphaladi Yog along with Thyroxine in the management of Galganda with special reference to Hypothyroidism
Dr Himani0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient already diagnosed as Primary Hypothyroidism and under Thyroxine medication with serum TSH level >5micro IU/ml to <30micro IU/ml.
- •2.Patinet who are ready to take Ayurvedic Medicine and sign informed consent form
排除标准
- •1.Patient suffering from systemic disease like cardiac disorders,Diabetes Mellitus ,COPD,TB,HIV,HCV,HBsAg
- •2.Immuno-compromised patients.
- •3.Pregnancy and lactating mother and renal insufficiency
- •4.Patient who are known case of congenital Hypothyroidism,secondary Hypothyroidism,Thyroid,Neoplasia and progressive cases of Myxedema coma.
- •5.Any serious medical and psychological condition will be excluded
研究者
相似试验
尚未招募
不适用
Management of Psoriasis with Kushtanashana rasa and Kutaja suryapaki taila -A clinical studyCTRI/2020/03/024089Dr Supreetha M
招募中
1 期
Randomized double-blind parallel controlled clinical trail of Chenpi enzyme in the treatment of hyperlipidemiaHyperlipidemiaITMCTR2000003313Guangdong Province Traditional Chinese Medical Hospital
尚未招募
1 期
Randomized double-blind parallel controlled clinical study of tangerine peel enzyme in the treatment of chronic functional constipatioITMCTR2000003314Guangdong Provinc Traditional Chinese Medical Hospital
已完成
3 期
A randomized controlled trial by a parallel group design in multi-institutions to evaluate the effectiveness of oral adjuvant chemotherapy using Leucovorin and Tegaful/Uracil to prevent recurrence after resection of liver metastasis from colorectal carcinoma.Cases with liver metastasis from colorectal carcinoma, which is removed curatively and surgically.JPRN-C000000013Hepato-Biliary-Pancreatic Surgery Division, Tokyo University Hospital180
进行中（未招募）
1 期
Randomized, parallel controlled study with routine clinical practice to evaluate the efficacy and tolerability of PRFC ENDORET® in the treatment of frontal fibrosing alopecia• Patients diagnosed with fibrosing frontal alopecia (FFA) with an age greater than or equal to 18 years.• Patient not responding to previous treatments for at least 6 months.• Use of effective physical or pharmacological contraceptive measures• Free acceptance to participate in the trial, with the written informed consent of the volunteer.EUCTR2021-000865-33-ESINSTITUTO DE INVESTIGACIÓN SANITARIA BIOARABA74